AzTrials
AzTrials

PregnancyNCT07906743

Mandala Coloring in Late Pregnancy

A study testing Mandala Coloring Group in people with Pregnancy and Anxiety, run by Fidan Balkaya at 1 site in Turkey (Türkiye).

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Anxiety, depression and poor sleep are common in the last months of pregnancy and often occur together. Medication options during pregnancy are limited, so simple, safe non-drug methods are needed. Read more about this study

Who is it for?
Ages 18 years and older, women onlyHealthy volunteers can take part
Conditions the study is for
Pregnancy, Anxiety, Depression
What is being tested?
Mandala Coloring Group
Could I receive a placebo?
No, everyone receives an active treatment
How many people
186 participants
Where
1 siteTurkey (Türkiye)
Study dates
10 Nov 2026to 28 Feb 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • • Presenting to the Obstetrics and Gynecology Outpatient Clinics of Malatya Training and Research Hospital
  • Being in the 28th week of gestation
  • Being 18 years of age or older
  • Having a singleton, low-risk (healthy) pregnancy
  • Being able to understand and speak Turkish and being literate
  • Agreeing to participate in the study voluntarily
  • Having no physical limitation preventing mandala coloring (being able to use hand and arm movements)

Who cannot join

  • Having a diagnosed psychiatric disorder or currently using psychotropic medication
  • Having a diagnosed sleep disorder or currently using sleep medication
  • Having a visual or cognitive impairment that prevents mandala coloring or completing the questionnaires
  • Currently participating in another psychological, art-based or mind-body program (e.g., art therapy, yoga, meditation, mindfulness)
  • Having a diagnosed pregnancy complication (e.g., preeclampsia, gestational diabetes, placenta previa, threatened preterm labor) at enrollment
  • Withdrawal Criteria:
Show all 10Show fewer
  • Developing a pregnancy complication requiring hospitalization or giving birth before the posttest assessment
  • Using any pharmacological or non-pharmacological method for anxiety, depression or sleep problems during the study
  • Not completing at least 75% of the coloring sessions (12 of 16) in the intervention group
  • Withdrawing consent at any time

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Turkey (Türkiye)1 site
  • Inonu University Faculty of Nursing

    Malatya, Battalgazi, 44280

Other trials in Turkey (Türkiye)

About this study

Official title: Effects of Mandala Art Therapy in Late Pregnancy on Expectant Mothers' Mental Health and Sleep: A Randomized Controlled Trial

Anxiety, depression and poor sleep are common in the last months of pregnancy and often occur together. Medication options during pregnancy are limited, so simple, safe non-drug methods are needed. Mandala coloring is an art therapy technique in which a person colors circular patterns; it helps focus attention on the present moment and may have a calming effect.

This randomized controlled trial will examine whether mandala coloring during the third trimester reduces depression, anxiety and stress, improves sleep, and reduces fear of childbirth. It will also look at birth outcomes and the childbirth experience. Pregnant women at 28 weeks of gestation who attend the obstetrics outpatient clinics of Malatya Training and Research Hospital will be randomly assigned to a mandala coloring group or a control group. Women in the mandala group will color two mandalas a week at home for 8 weeks (16 mandalas in total, about 20-30 minutes per session). Women in the control group will receive routine antenatal care only and will be offered the mandala materials after the study ends.

Read the detailed description

Background Pregnancy involves physiological, psychological, hormonal and social changes. Pregnancy-related anxiety affects about 15-23% of pregnant women, and the prevalence of antenatal depression ranges from 15% to 65%, becoming more marked in the third trimester. Poor sleep quality affects 29-76% of pregnant women and reaches about 60% in the third trimester. Sleep problems, anxiety and depression are closely linked and reinforce one another. These problems are associated with adverse maternal and neonatal outcomes, including postpartum mental health problems, low birth weight, preterm birth, preeclampsia, gestational diabetes and cesarean delivery. Because pharmacological treatment is used cautiously in pregnancy, non-pharmacological approaches are important. Mandala coloring has reduced anxiety and depressive symptoms in various populations and has reduced anxiety and fear of childbirth in pregnant women. However, most studies have examined a single outcome over a short follow-up period, and few have assessed anxiety, depression and sleep together while following women until birth.

Objective To evaluate the effect of mandala coloring in the third trimester on depression, anxiety, stress, insomnia, fear of childbirth, childbirth experience and birth outcomes.

Design Two-arm, parallel-group, randomized controlled trial.

Setting and period Obstetrics and Gynecology Outpatient Clinics of Malatya Training and Research Hospital, Malatya, Türkiye; November 2027 - February 2028.

Participants Pregnant women aged 18 years or older at 28 weeks of gestation with a singleton, low-risk pregnancy who can understand, speak, read and write Turkish, have no physical limitation that prevents coloring, and agree to participate voluntarily.

Randomization and allocation concealment Participants will be randomized 1:1 to the intervention or control group using a computer-generated block randomization list with a block size of 4. The list will be prepared by a researcher independent of the study, and allocation will be concealed using sequentially numbered, opaque, sealed envelopes.

Intervention group Participants will receive a standard verbal and written briefing on the purpose, duration, session frequency and materials of the intervention. Each participant will receive a set of 7-color felt-tip pens and 16 ready-made mandala templates of her choice. She will color two mandalas a week for 8 weeks (16 sessions in total, about 20-30 minutes each) at home, at a time convenient for her, in a calm and quiet setting. To monitor adherence, participants will send a message to the researcher before each session and a photograph of the completed mandala afterwards. Regular reminder messages will be sent throughout the intervention.

Control group Participants will continue their routine antenatal care and will receive no intervention. Participants found to use any pharmacological or non-pharmacological method for the study outcomes during the study period will be excluded. After the study is completed, mandala coloring information and materials will be offered to the control group.

Outcome measures and time points

  • Pretest (28 weeks of gestation, before the intervention): Personal Information Form, Depression Anxiety Stress Scale-21 (DASS-21), Women's Health Initiative Insomnia Rating Scale (WHIIRS) and Wijma Delivery Expectancy/Experience Questionnaire Version A (W-DEQ A).
  • Posttest (after the 8-week intervention, before birth): DASS-21, WHIIRS and W-DEQ A.
  • Postpartum: Wijma Delivery Expectancy/Experience Questionnaire Version B (W-DEQ B) and the Postpartum Parameters Form (mode of delivery, duration of labor, birth weight, 1- and 5-minute Apgar scores, gestational age at birth, and maternal/neonatal complications), recorded from patient files and delivery records.

Data will be collected by the researcher through face-to-face interviews.

Sample size G*Power 3.1 power analysis (one-tailed, α = 0.05, power = 0.95, effect size d = 0.50) indicated 88 participants per group. Allowing for 5% attrition, 93 participants per group (186 in total) will be recruited.

Statistical analysis Data will be analyzed with SPSS 22.0. Descriptive statistics (number, percentage, mean, standard deviation), the chi-square test, the independent samples t-test, the paired samples t-test or repeated measures analysis of variance, and Cronbach's alpha will be used.

Being tested
Mandala Coloring Group
Keywords
Mandala coloring, Art therapy, Third trimester, Prenatal anxiety, Antenatal depression, Sleep quality, Childbirth experience, Non-pharmacological intervention
Medical subject headings
Anxiety Disorders, Depression, Stress, Psychological, Sleep Initiation and Maintenance Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Mandala Coloring GroupBehavioural

    Participants color two ready-made mandala templates per week for 8 weeks (16 sessions in total, approximately 20-30 minutes each) at home, at a time convenient for them, in a calm and quiet setting. Each participant receives a set of 7-color felt-tip pens and 16 mandala templates of her choice, together with a standard verbal and written briefing on the purpose, duration, session frequency and materials of the intervention. Adherence is monitored through a message sent to the researcher before each session and a photograph of the completed mandala sent afterwards; regular reminder messages are sent throughout the intervention.

Study groups in NCT07906743
Study groupRoleWhat they receive
Mandala Coloring GroupExperimentalBefore the study begins, participants in the experimental group will receive a standard briefing on the mandala coloring intervention from the researcher. In this briefing, participants will be given verbal and written information on the purpose and duration of the intervention, the frequency of sessions and the materials to be used. The intervention will be continued for a total of 8 weeks, with 2 sessions per week. During this period, participants will color 2 mandalas each week, 16 mandalas in total. Each session is planned to last approximately 20-30 minutes.
Receives: Behavioral: Mandala Coloring Group
Control GroupNo interventionParticipants continue their routine antenatal care and receive no intervention during the study. After the study is completed, mandala coloring information and materials will be offered to this group.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Depression Score (DASS-21 Depression Subscale)

    Depression will be assessed with the depression subscale of the Depression Anxiety Stress Scale-21 (DASS-21). The subscale consists of 7 items rated on a 4-point Likert scale (0-3); the subscale score is multiplied by two, giving a range of 0 to 42. Higher scores indicate more severe depression.

    Measured: aseline (28 weeks of gestation) and after the 8-week intervention (36 weeks of gestation)

Secondary outcomes (1)
  1. Change in Anxiety Score (DASS-21 Anxiety Subscale)

    Anxiety will be assessed with the anxiety subscale of the Depression Anxiety Stress Scale-21 (DASS-21). The subscale consists of 7 items rated on a 4-point Likert scale (0-3); the subscale score is multiplied by two, giving a range of 0 to 42. Higher scores indicate more severe anxiety.

    Measured: Baseline (28 weeks of gestation) and after the 8-week intervention (36 weeks of gestation)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Oct 2026
  2. Study start10 Nov 2026 (estimated)
  3. Primary completion5 Jan 2027 (estimated)
  4. Study completion28 Feb 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
The study will be conducted using a two-arm, parallel-group randomized controlled design with an experimental group and a control group.
Masking
None (open label)
Enrolment
186 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07906743
Sponsor's protocol ID
Inonu Faculty of Nursing
Status last verified
Oct 2026
First submitted
26 Oct 2026
Last updated
30 Oct 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data will not be shared. Participants were not asked to consent to the sharing of their data with third parties, and the ethics committee approval covers the use of the data by the research team only. To protect the confidentiality of participants, who are pregnant women recruited from a single hospital, the data will be stored securely by the research team and used only for the purposes of this study. Aggregate results will be reported in peer-reviewed publications.

Questions about this trial

What is this clinical trial studying?

A study testing Mandala Coloring Group in people with Pregnancy and Anxiety, run by Fidan Balkaya at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 30 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Fidan Balkaya, PhD (+90 422 377 30 00 ext. 0000, fidan.balkaya@inonu.edu.tr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Depression Score (DASS-21 Depression Subscale) (time frame: aseline (28 weeks of gestation) and after the 8-week intervention (36 weeks of gestation)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in